TCF7 Antibody (N-term) Blocking Peptide
€363.00
In stock
SKU
AC-BP1951a
Background:
The T cell specific transcription factor TCF7 activates genes involved in immune regulation and thymocyte differentiation, and is a candidate locus for genetic susceptibility to type 1 diabetes.
Other Names:
Transcription factor 7, TCF-7, T-cell-specific transcription factor 1, T-cell factor 1, TCF-1, TCF7, TCF1
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP1951a was selected from the N-term region of human TCF7. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: TCF7
Gene ID: 6932
Primary Accession: P36402
Other Accession: Q86WR9
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
The T cell specific transcription factor TCF7 activates genes involved in immune regulation and thymocyte differentiation, and is a candidate locus for genetic susceptibility to type 1 diabetes.
Other Names:
Transcription factor 7, TCF-7, T-cell-specific transcription factor 1, T-cell factor 1, TCF-1, TCF7, TCF1
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP1951a was selected from the N-term region of human TCF7. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: TCF7
Gene ID: 6932
Primary Accession: P36402
Other Accession: Q86WR9
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review